This will hasten the development of the COVID-19 vaccine
KRC TIMES Desk
The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India.
This will hasten the development of the COVID-19 vaccine.
